Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 1: An overview

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Coordination Chemistry Reviews

• Publication date

  2012-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CCR.2012.03.037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases

  2012cited by this paper
• Copper(II) interaction with amyloid-β: Affinity and speciation

  2012cited by this paper
• Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain.

  2012cited by this paper
• Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases

  2012cited by this paper
• Reevaluation of copper(I) affinity for amyloid-β peptides by competition with ferrozine--an unusual copper(I) indicator.

  2012cited by this paper
• The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

  2012cited by this paper
• Role of metal dyshomeostasis in Alzheimer's disease.

  2011cited by this paper
• Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease

  2011cited by this paper
• Active site environment of heme-bound amyloid β peptide associated with Alzheimer's disease.

  2011cited by this paper
• pH-Dependent Cu(II) coordination to amyloid-β peptide: impact of sequence alterations, including the H6R and D7N familial mutations.

  2011cited by this paper
• Low‐n oligomers as therapeutic targets of Alzheimer’s disease

  2011cited by this paper
• The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.

  2011cited by this paper
• New insights into the coordination of Cu(II) by the amyloid-B 16 peptide from Fourier transform IR spectroscopy and isotopic labeling.

  2011cited by this paper
• Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides*

  2011cited by this paper
• Exploring the reactions of β-amyloid (Aβ) peptide 1-28 with Al(III) and Fe(III) ions.

  2011cited by this paper
• Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation.

  2011cited by this paper
• Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’

  2011cited by this paper
• Iron(II) binding to amyloid-β, the Alzheimer's peptide.

  2011cited by this paper
• Presynaptic protein synthesis required for NT-3-induced long-term synaptic modulation

  2011cited by this paper
• Copper(II) coordination to amyloid β: murine versus human peptide.

  2011cited by this paper
• Affinity of Cu+ for the copper-binding domain of the amyloid-β peptide of Alzheimer's disease.

  2011cited by this paper
• Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.

  2011cited by this paper
• Zinc(II) modulates specifically amyloid formation and structure in model peptides

  2011cited by this paper
• Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer Disease*

  2011cited by this paper
• Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy.

  2011cited by this paper
• Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

  2011cited by this paper
• Alzheimer’s Disease: The Challenge of the Second Century

  2011cited by this paper
• Systems neuroscience: The stress of dieting

  2011cited by this paper
• Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.

  2011cited by this paper
• Copper(I) and copper(II) binding to β-amyloid 16 (Aβ16) studied by electrospray ionization mass spectrometry.

  2010cited by this paper
• Affinity gradients drive copper to cellular destinations

  2010cited by this paper
• A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease

  2010cited by this paper
• Quantification of the binding properties of Cu2+ to the amyloid beta peptide: coordination spheres for human and rat peptides and implication on Cu2+-induced aggregation.

  2010cited by this paper
• Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-β from Alzheimer Disease*

  2010cited by this paper
• Electrochemical and homogeneous electron transfers to the Alzheimer amyloid-β copper complex follow a preorganization mechanism

  2010cited by this paper
• Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

  2010cited by this paper
• Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation*

  2010cited by this paper
• Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers.

  2010cited by this paper
• Tau in Alzheimer disease and related tauopathies.

  2010cited by this paper
• Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment

  2010cited by this paper
• Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

  2010cited by this paper
• Dissecting the telomere region of barley chromosome 5HL using rice genomic sequences as references: new markers for tracking a complex region in breeding

  2010cited by this paper
• Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1-16 amyloid-beta peptide: a key role of the first two N-terminus residues.

  2009cited by this paper
• MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice

  2009cited by this paper
• Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.

  2009cited by this paper
• Amyloid β-Protein Assembly and Alzheimer Disease*

  2009cited by this paper
• Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

  2009cited by this paper
• Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in a Drosophila model of Alzheimer’s disease

  2009cited by this paper
• Overexpression of amyloid precursor protein increases copper content in HEK293 cells.

  2009cited by this paper
• Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.

  2009cited by this paper
• Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators

  2009cited by this paper
• Brain proteins that mind metals: a neurodegenerative perspective.

  2009cited by this paper
• Importance of dynamical processes in the coordination chemistry and redox conversion of copper amyloid-β complexes

  2009cited by this paper
• Deprotonation of the Asp1-Ala2 peptide bond induces modification of the dynamic copper(II) environment in the amyloid-beta peptide near physiological pH.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation)

  2009cited by this paper
• Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.

  2009cited by this paper
• Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.

  2009cited by this paper
• Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.

  2009cited by this paper
• The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.

  2009cited by this paper
• Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form.

  2009cited by this paper
• A potential pathogenetic role of iron in Alzheimer's disease

  2008cited by this paper
• Amyloid Precursor Protein Trafficking, Processing, and Function*

  2008cited by this paper
• Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.

  2008cited by this paper
• Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.

  2008cited by this paper
• Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

  2008cited by this paper
• Identifying the Minimal Copper- and Zinc-binding Site Sequence in Amyloid-β Peptides*

  2008cited by this paper
• Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity

  2008cited by this paper
• Structural studies of copper(I) complexes of amyloid-beta peptide fragments: formation of two-coordinate bis(histidine) complexes.

  2008cited by this paper
• Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.

  2008cited by this paper
• Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide

  2008cited by this paper
• Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.

  2008cited by this paper
• The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.

  2008cited by this paper
• The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease.

  2008cited by this paper
• Metal based neurodegenerative diseases - From molecular mechanisms to therapeutic strategies

  2008cited by this paper
• Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease

  2007cited by this paper
• Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance†

  2007cited by this paper
• The redox chemistry of the Alzheimer's disease amyloid β peptide

  2007cited by this paper
• Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Redox Chemistry of Copper–Amyloid‐β: The Generation of Hydroxyl Radical in the Presence of Ascorbate is Linked to Redox‐Potentials and Aggregation State

  2007cited by this paper
• Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.

  2007cited by this paper
• Zinc lowers amyloid-beta toxicity by selectively precipitating aggregation intermediates.

  2007cited by this paper
• Structure of Alzheimer's disease amyloid precursor protein copper-binding domain at atomic resolution.

  2007cited by this paper
• Synthesis and X-ray absorption spectroscopy structural studies of Cu(I) complexes of histidylhistidine peptides: the predominance of linear 2-coordinate geometry.

  2007cited by this paper
• APP at a glance

  2007cited by this paper
• Copper binding to the Alzheimer’s disease amyloid precursor protein

  2007cited by this paper
• Metals ions and neurodegeneration

  2007cited by this paper
• Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.

  2007cited by this paper
• Molecular structure of amyloid fibrils: insights from solid-state NMR

  2006cited by this paper
• Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

  2006cited by this paper
• Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.

  2006cited by this paper
• Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer’s disease

  2006cited by this paper
• Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

  2006cited by this paper
• Metals and Alzheimer's disease

  2006cited by this paper
• Zinc(II) binds to the neuroprotective peptide humanin.

  2006cited by this paper
• Aluminium and iron, but neither copper nor zinc, are key to the precipitation of β-sheets of Aβ42 in senile plaque cores in Alzheimer's disease

  2006cited by this paper
• Redox cycling of iron by Aβ42

  2006cited by this paper
• Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-β Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity*

  2005cited by this paper
• The amyloid‐β precursor protein: integrating structure with biological function

  2005cited by this paper

• From simple to complex: multiscale modeling of metal-mediated protein interactions to uncover mechanistic insights into the action of inorganic drugs

  2026cites this paper
• Cu(I) chelators: Useful tools to reveal and control Cu(I) homeostasis and toxicity

  2025cites this paper
• Copper homeostasis and cuproptosis in Alzheimer's disease (Review)

  2025cites this paper
• Nano-conjugation of small molecule modulators of protein aggregation: Enhancing the therapeutic precision.

  2025cites this paper
• In Situ Activatable Hydrogen-Bonded Organic Framework-Based Nanozyme as NADH Peroxidase Mimic Restoring Homeostasis for Treatment of Alzheimer's Disease.

  2025cites this paper
• Modeling Chelator Substituent Effects as Therapeutic Targets in Neurodegenerative Diseases

  2025cites this paper
• Evaluation of a New Methylimidazole‐Containing Thiosemicarbazone as a Cu+/Cu2+‐Targeting Ligand in the Context of Alzheimer's Disease

  2025cites this paper
• Cu(I) Is a Game Changer in the Arrest of Cu(Aβ)-Induced ROS Production in the Presence of Competing Zn(II) Ions.

  2025cites this paper
• Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.

  2024cites this paper
• Examining the role of antioxidant supplementation in mitigating oxidative stress markers in Alzheimer’s disease: a comprehensive review

  2024cites this paper
• A cocktail of Cu2+- and Zn2+-peptoid-based chelators can stop ROS formation for Alzheimer's disease therapy

  2024cites this paper
• An N-terminal acidic β-sheet domain is responsible for the metal-accumulation properties of amyloid-β protofibrils: a molecular dynamics study

  2024cites this paper
• Investigating the combined effect of copper, zinc, and iron ions on truncated and full-length Aβ peptides: insights from molecular dynamics simulation

  2024cites this paper
• A Robust Strontium Coordination Polymer with Selective and Sensitive Fluorescence Sensing Ability for Fe3+ Ions

  2023cites this paper
• Metal ion mediated aggregation of Alzheimer's disease peptides and proteins in solutions and at surfaces.

  2023cites this paper
• Metal Binding of Alzheimer’s Amyloid-β and Its Effect on Peptide Self-Assembly

  2023cites this paper
• Revisit the E2 Domain of Amyloid Precursor Protein: Ferroxidase, Superoxide and Peroxynitrite Scavenging Activities.

  2023cites this paper
• Guluronic acid can inhibit copper(II) and amyloid - β peptide coordination and reduce copper-related reactive oxygen species formation associated with Alzheimer's disease.

  2023cites this paper
• Influence of Metal Cations on the Viscoelastic Properties of Escherichia coli Biofilms

  2022cites this paper
• Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer’s-Related Aβ Peptide

  2022cites this paper
• Curcumin Scaffold as a Multifunctional Tool for Alzheimer’s Disease Research

  2022cites this paper
• Neuroprotective Activity of a Novel Synthetic Rhodamine-Based Hydrazone against Cu2+-Induced Alzheimer's Disease in Drosophila.

  2022cites this paper
• Influence of d-Electron Divalent Metal Ions in Complex Formation with L-Tartaric and L-Malic Acids

  2021cites this paper
• Biogenic metallic elements in the human brain?

  2021cites this paper
• Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology

  2021cites this paper
• Tau/Aβ chimera peptides: a Thioflavin-T and MALDI-TOF study of Aβ amyloidosis in the presence of Cu(II) or Zn(II) ions and Total Lipid Brain Extract (TLBE) vesicles.

  2021cites this paper
• The interplay between lipid and Aβ amyloid homeostasis in Alzheimer's Disease: risk factors and therapeutic opportunities.

  2021cites this paper
• Copper (II) binding properties of an octapeptide fragment from the R3 region of tau protein: A combined potentiometric, spectroscopic and mass spectrometric study.

  2021cites this paper
• Unusual Pseudopeptides: Syntheses and Structural Analyses of Ethylenediprolyl Peptides and Their Metal Complexes with Cu(II) Ion.

  2021cites this paper
• In vitro coordination of Fe-protoheme with amyloid β is non-specific and exhibits multiple equilibria.

  2021cites this paper
• Salpyran: A Cu(II) Selective Chelator with Therapeutic Potential.

  2021cites this paper
• A Water-Soluble Peptoid Chelator that Can Remove Cu2+ from Amyloid-β and Stop the Formation of Reactive Oxygen Species Associated with Alzheimer's Disease.

  2021cites this paper
• N-truncated Aβ peptides impact on Cu and Cu(Aβ)-generated ROS: Cu(I) matters !

  2020cites this paper
• The aroylhydrazone INHHQ prevents memory impairment induced by Alzheimer’s-linked amyloid-β oligomers in mice

  2020cites this paper
• Novel Perspective on Alzheimer’s Disease Treatment: Rosmarinic Acid Molecular Interplay with Copper(II) and Amyloid β

  2020cites this paper
• Carnoquinolines Target Copper Dyshomeostasis, Aberrant Protein-Protein Interactions, and Oxidative Stress.

  2020cites this paper
• Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease

  2020cites this paper
• Copper Complexation by Peptides Implicated in Neurodegenerative Diseases

  2020cites this paper
• Designed Metal-ATCUN Derivatives: Redox- and Non-redox-Based Applications Relevant for Chemistry, Biology, and Medicine

  2020cites this paper
• Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015–Present: Synthesis and Biological Activity

  2020cites this paper
• Transition Metal Ion Interactions with Disordered Amyloid-β Peptides in the Pathogenesis of Alzheimer's Disease: Insights from Computational Chemistry Studies

  2019influential citation
• Effects of Metal Ions on Aβ42 Peptide Conformations from Molecular Simulation Studies

  2019cites this paper
• Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.

  2019cites this paper
• Cu2+ effects on beta-amyloid oligomerisation monitored by fluorescence of intrinsic tyrosine.

  2019cites this paper
• Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic

  2019cites this paper
• CuII Binding Properties of N-Truncated Aβ Peptides: In Search of Biological Function.

  2019cites this paper
• Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.

  2019cites this paper
• Interaction of metal ions with tau protein. The case for a metal-mediated tau aggregation.

  2019cites this paper
• Role of PTA in the prevention of Cu(amyloid-β) induced ROS formation and amyloid-β oligomerisation in the presence of Zn.

  2019cites this paper
• Cu(II) binding to various forms of amyloid-β peptides. Are they friends or foes?

  2018cites this paper
• Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals

  2018cites this paper
• RTHLVFFARK-NH2: A potent and selective modulator on Cu2+-mediated amyloid-β protein aggregation and cytotoxicity.

  2018cites this paper
• N-Terminal Cu-Binding Motifs (Xxx-Zzz-His, Xxx-His) and Their Derivatives: Chemistry, Biology and Medicinal Applications.

  2018cites this paper
• Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.

  2018cites this paper
• Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress

  2018cites this paper
• Carboxyl groups of citric acid in the process of complex formation with bivalent and trivalent metal ions in biological systems.

  2018cites this paper
• Effect of ferric citrate on amyloid‐beta peptides behavior

  2018cites this paper
• Mutations of Histidine 13 to Arginine and Arginine 5 to Glycine Are Responsible for Different Coordination Sites of Zinc(II) to Human and Murine Peptides.

  2018cites this paper
• Magnetite Fe3 O4 Has no Intrinsic Peroxidase Activity, and Is Probably not Involved in Alzheimer's Oxidative Stress.

  2018cites this paper
• Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance.

  2018cites this paper
• Copper signalling: causes and consequences

  2018cites this paper
• Structural and functional characterization of β-sheet heme binding peptides : de novo designed and naturally occurring

  2018cites this paper
• Interaction of Amyloid Aβ(9–16) Peptide Fragment with Metal Ions: CD, FT-IR, and Fluorescence Spectroscopic Studies

  2018cites this paper
• Metal Ions and Complexes in Alzheimer's Disease: From Fundamental to Therapeutic Perspectives

  2018cites this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cites this paper
• Ascorbate oxidation by Cu(Amyloid- β ) complexes: determination of the intrinsic rate as function of alterations in the peptide sequence reveals key residues for ROS production

  2018cites this paper
• Identification of key structural features of the elusive Cu–Aβ complex that generates ROS in Alzheimer’s disease

  2017cites this paper
• Alzheimer’s disease: How metal ions define β-amyloid function

  2017cites this paper
• Link between Affinity and Cu(II) Binding Sites to Amyloid-β Peptides Evaluated by a New Water-Soluble UV-Visible Ratiometric Dye with a Moderate Cu(II) Affinity.

  2017cites this paper
• Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses

  2017cites this paper
• Synthesis, Characterization, and Activity of a Triazine Bridged Antioxidant Small Molecule.

  2017cites this paper
• The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu2+ -Aβ Complex.

  2017cites this paper
• Cu in biology: Unleashed by O2 and now irreplaceable

  2017cites this paper
• Real-time evolution of Aβ40 metal-catalyzed oxidation reveals Asp1 as the main target and a dependence on metal binding site

  2017cites this paper
• Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

  2017cites this paper
• Nouvelles preuves de concept pour la chélatothérapie contre la maladie d'Alzheimer : études spectroscopiques des interactions entre les ions cuivre et zinc

  2017cites this paper
• Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level

  2017cites this paper
• Copper binding and redox chemistry of the Aβ16 peptide and its variants: insights into determinants of copper-dependent reactivity.

  2017cites this paper
• A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

  2017cites this paper
• Controlling surface mediated insulin aggregation by peptides and light

  2017cites this paper
• Metal-Binding to Amyloid-β Peptide: Coordination, Aggregation, and Reactive Oxygen Species Production

  2017cites this paper
• On the ability of CuAβ1-x peptides to form ternary complexes: Neurotransmitter glutamate is a competitor while not a ternary partner.

  2016cites this paper
• Copper Coordination Features of Human Islet Amyloid Polypeptide: The Type 2 Diabetes Peptide.

  2016cites this paper
• Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides

  2016cites this paper
• Effects of hydroxyl group variations on a flavonoid backbone toward modulation of metal-free and metal-induced amyloid-β aggregation

  2016cites this paper
• How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study

  2016cites this paper
• Tuning the Redox Properties of Copper(II) Complexes with Amyloid-β Peptides

  2016cites this paper
• Influence of membrane environments and copper ions on the structural features of amyloidogenic proteins correlated to neurodegeneration

  2016cites this paper
• Stability of transient Cu+Aβ (1–16) species and influence of coordination and peptide configuration on superoxide formation

  2016cites this paper
• Involvement of Free Radicals in the Development and Progression of Alzheimer’s Disease

  2016cites this paper
• Coordinating properties of peptides containing histidyl residues

  2016cites this paper
• Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease

  2016cites this paper
• Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production

  2016cites this paper
• Is ascorbate Dr Jekyll or Mr Hyde in the Cu(Aβ) mediated oxidative stress linked to Alzheimer’s disease?

  2016cites this paper
• Amyloid-β and α-Synuclein Decrease the Level of Metal-Catalyzed Reactive Oxygen Species by Radical Scavenging and Redox Silencing

  2016cites this paper
• Copper Oxidation/Reduction in Water and Protein: Studies with DFTB3/MM and VALBOND Molecular Dynamics Simulations.

  2016cites this paper
• Metallothioneins in Prion- and Amyloid-Related Diseases

  2016cites this paper
• Key roles of Tyr 10 in Cu bound Aβ complexes and its relevance to Alzheimer's disease.

  2015cites this paper
• Copper(I/II), α/β‐Synuclein and Amyloid‐β: Menage à Trois?

  2015cites this paper
• Design of a structural framework with potential use to develop balanced multifunctional agents against Alzheimer's disease

  2015cites this paper